CLINICAL_TRIALS
trial_result
· 2013-09-11
Clinical Trial Update: 400mcg Sublingual Misoprostol as First Line Treatment [NA]
Summary
A completed clinical trial evaluating 400 mcg of sublingual misoprostol as a first-line treatment for incomplete abortion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gynuity Health Projects | Conditions: Incomplete Abortion | NA | Status: COMPLETED